SEC Form 4 · accession 0001140361-15-005488
VASCULAR SOLUTIONS INC · VASC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Howard Root
Officer — Chief Executive Officer · Director
Period of report
Feb 9, 2015
Accepted (ET)
Feb 11, 2015 · 4:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001030206
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 9, 2015 | S | 25,000 | $28.57 | D | 415,411 | D | |
| Common Stock | holding | — | — | — | 440,411 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | — | holding | — | — | — | — | Jan 27, 2022 | Common Stock | 450,000 | 450,000 | D |
Explanation of responses
- F1The shares were sold pursuant to a Rule 10b5-1 trading plan.
- F2The price in column 4 is a weighted average price. The prices actually received for the stock ranged from $28.50 to $28.72 per share. Mr. Root has provided to the Company and, upon request, will provide any security holder of the Company or the SEC staff information regarding the number of shares sold at each price within that range.
- F390,000 shares vested on January 27, 2013 with an exercise price of $11.03/share. 90,000 shares vested on January 27, 2014 with an exercise price of $12.03/share. 90,000 shares vested on January 27, 2015 with an exercise price of $13.03/share. 90,000 shares vest on January 27, 2016 with an exercise price of $14.03/share. 90,000 shares vest on January 27, 2017 with an exercise price of $15.03/share.